Menzies-Gow, Andrew

The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry

O'Neill, S., Sweeney, J., Patterson, C. C., Menzies-Gow, A., Niven, R., Mansur, A. H., Bucknall, C., Chaudhuri, R., Thomson, N. C., Brightling, C. E., et al. (2015) · Thorax

Asthma and respiratory diseasesHealth Systems, Economic Evaluations, Quality of Life

Cited by 186

Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study

Menzies-Gow, A., Gurnell, M., Heaney, L. G., Corren, J., Bel, E. H., Maspero, J., Harrison, T., Jackson, D. J., Price, D., Lugogo, N., et al. (2022) · The Lancet Respiratory Medicine

Asthma and respiratory diseasesAdrenal Hormones and Disorders

Cited by 177

Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study

Suehs, C. M., Menzies-Gow, A., Price, D., Bleecker, E. R., Canonica, G. W., Gurnell, M., & Bourdin, A. (2021) · American Journal of Respiratory and Critical Care Medicine

Asthma and respiratory diseasesAdrenal Hormones and Disorders

Cited by 118

DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma

Menzies-Gow, A., Ponnarambil, S., Downie, J., Bowen, K., Hellqvist, Å., & Colice, G. (2020) · Respiratory Research

Asthma and respiratory diseasesAllergic Rhinitis and Sensitization

Cited by 71

A randomised controlled feasibility trial of Group Cognitive Behavioural Therapy for people with severe asthma

Yorke, J., Adair, P., Doyle, A.-M., Dubrow-Marshall, L., Fleming, S., Holmes, L., Menzies-Gow, A., Niven, R., Pilling, M., & Shuldham, C. (2017) · Journal of Asthma

Asthma and respiratory diseasesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 34